Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Otorhinolaryngology

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 126 articles:
HTML format



Single Articles


    May 2020
  1. LI H, Chen X, Zeng W, Zhou W, et al
    Radiation-enhanced expression of CCL22 in nasopharyngeal carcinoma is associated with CCR4(+) CD8 T cell recruitment.
    Int J Radiat Oncol Biol Phys. 2020 May 16. pii: S0360-3016(20)31125.
    PubMed     Abstract available


  2. LIU Q, Zhu Z, Chen Y, Deng J, et al
    Phase II Study of SBRT for Patients With Oligometastatic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 May 14. pii: S0360-3016(20)31127.
    PubMed     Abstract available


  3. GUPTA T, Agarwal JP, Bentzen SM
    Comment on "Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiotherapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement".
    Int J Radiat Oncol Biol Phys. 2020 May 13. pii: S0360-3016(20)31075.
    PubMed    


    April 2020
  4. GOUW ZAR, Fontaine, Vogel WV, van de Kamer JB, et al
    Single-center prospective trial investigating the feasibility of serial FDG-PET guided adaptive radiotherapy for head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2020 Apr 30. pii: S0360-3016(20)31056.
    PubMed     Abstract available


  5. THOMSON DJ, Palma D, Guckenberger M, Balermpas P, et al
    Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement.
    Int J Radiat Oncol Biol Phys. 2020 Apr 14. pii: S0360-3016(20)31034.
    PubMed     Abstract available


  6. FISHER MM, SenthilKumar G, Hu R, Goldstein S, et al
    Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas.
    Int J Radiat Oncol Biol Phys. 2020 Apr 13. pii: S0360-3016(20)30984.
    PubMed     Abstract available


  7. E LONGTON MD, Lawson G, Bihin B, Mathieu I, et al
    Individualized prophylactic neck irradiation in cN0 head and neck cancer patients based on sentinel lymph node(s) identification: definitive results of a prospective phase I-II study.
    Int J Radiat Oncol Biol Phys. 2020 Apr 12. pii: S0360-3016(20)30949.
    PubMed     Abstract available


  8. PORCEDDU SV, Daniels C, Yom SS, Liu H, et al
    Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the delivery of postoperative radiation therapy in complex cutaneous squamous cell carcinoma of the head and neck (cSCCHN).
    Int J Radiat Oncol Biol Phys. 2020 Apr 11. pii: S0360-3016(20)30952.
    PubMed     Abstract available


  9. MIAO J, Di M, Chen B, Wang L, et al
    A Prospective 10-year Observational Study of Reduction of Radiotherapy Clinical Target Volume and Dose in Early-stage Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 Apr 6. pii: S0360-3016(20)30959.
    PubMed     Abstract available


    March 2020
  10. SWISHER-MCCLURE S, Lukens JN, Aggarwal C, Ahn P, et al
    A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
    Int J Radiat Oncol Biol Phys. 2020;106:725-732.
    PubMed     Abstract available


  11. MADDALO M, Borghetti P, Tomasini D, Corvo R, et al
    CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL.
    Int J Radiat Oncol Biol Phys. 2020 Mar 14. pii: S0360-3016(20)30887.
    PubMed     Abstract available



  12. Erratum to: Huang X-D, Li Y-C, Chen F-P, Zheng W-H, Zhou G-Q, Lin L, Hu J, He W-J, Zhang L-L, Kou J, Ma J, Zhang W-D, Qi Z-Y, and Sun Y. Evolution and Dosimetric Analysis of Magnetic Resonance Imaging-Detected Brain Stem Injury After Intensity Modulat
    Int J Radiat Oncol Biol Phys. 2020;106:651.
    PubMed    


    February 2020
  13. HUANG SH
    In Reply to Duprez et al.
    Int J Radiat Oncol Biol Phys. 2020;106:450-451.
    PubMed    


  14. DUPREZ F, Creytens D, De Neve W, Deron P, et al
    In Regard to Billfalk-Kelly et al.
    Int J Radiat Oncol Biol Phys. 2020;106:449-450.
    PubMed    


    January 2020
  15. ZHOU S, Yang H, Zhang J, Wang J, et al
    Changes in indoleamine 2,3-dioxygenase 1 expression and CD8+ tumor-infiltrating lymphocytes after neoadjuvant chemoradiotherapy and prognostic significance in esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 Jan 28. pii: S0360-3016(20)30126.
    PubMed     Abstract available


  16. BORGGREVE AS, Goense L, van Rossum PSN, Heethuis SE, et al
    Preoperative prediction of pathologic response to neoadjuvant chemoradiotherapy in patients with esophageal cancer using (18)F-FDG PET/CT and DW-MRI: a prospective multicenter study.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30052.
    PubMed     Abstract available


  17. CHOU WC, Chang PH, Chen PT, Wang HM, et al
    Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30057.
    PubMed     Abstract available


  18. LIU C, Patel SH, Shan J, Schild SE, et al
    Robust Optimization for Intensity-Modulated Proton Therapy to Redistribute High Linear Energy Transfer (LET) from Nearby Critical Organs to Tumors in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30072.
    PubMed     Abstract available


  19. SHER DJ, Timmerman RD, Nedzi L, Ding C, et al
    In Reply to Mendenhall et al.
    Int J Radiat Oncol Biol Phys. 2020;106:221.
    PubMed    


  20. MENDENHALL WM, Holtzman AL, Dagan R, Bryant CM, et al
    In Regard to Sher et al.
    Int J Radiat Oncol Biol Phys. 2020;106:220-221.
    PubMed    


  21. DERESSA BT, Tigeneh W, Bogale N, Buwenge M, et al
    Short-Course 2-Dimensional Radiation Therapy in the Palliative Treatment of Esophageal Cancer in a Developing Country: A Phase II Study (Sharon Project).
    Int J Radiat Oncol Biol Phys. 2020;106:67-72.
    PubMed     Abstract available


  22. ADEBERG S, Akbaba S, Lang K, Held T, et al
    The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
    Int J Radiat Oncol Biol Phys. 2020;106:167-173.
    PubMed     Abstract available


  23. MORALES CZ, McDowell L, Lisy K, Piper A, et al
    Return to Work in Survivors of Human Papillomavirus-Associated Oropharyngeal Cancer: An Australian Experience.
    Int J Radiat Oncol Biol Phys. 2020;106:146-156.
    PubMed     Abstract available


    December 2019

  24. Erratum to: Lee AW, Ng WT, Pan JJ, et al. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2019;105:567-580.
    Int J Radiat Oncol Biol Phys. 2019;105:1166-1167.
    PubMed    


  25. POTEZ M, Fernandez-Palomo C, Bouchet A, Trappetti V, et al
    Synchrotron Microbeam Radiation Therapy as a New Approach for the Treatment of Radioresistant Melanoma: Potential Underlying Mechanisms.
    Int J Radiat Oncol Biol Phys. 2019;105:1126-1136.
    PubMed     Abstract available


    November 2019
  26. CHEN BB, Lu SY, Peng H, Sun FF, et al
    Comparison of long-term outcomes and sequelae between children and adult nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Int J Radiat Oncol Biol Phys. 2019 Nov 30. pii: S0360-3016(19)34080.
    PubMed     Abstract available


  27. MADDALO M, Triggiani L, Magrini SM Prof, Buglione M, et al
    Cetuximab and Radiation Therapy in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2019;105:678-679.
    PubMed    


  28. VERBAKEL WFAR, Doornaert PAH, Raaijmakers CPJ, Bos LJ, et al
    Targeted Intervention to Improve the Quality of Head and Neck Radiation Therapy Treatment Planning in the Netherlands: Short and Long-Term Impact.
    Int J Radiat Oncol Biol Phys. 2019;105:514-524.
    PubMed     Abstract available


    October 2019
  29. DUNN LA, Riaz N, Fury MG, McBride SM, et al
    A Phase Ib Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity-Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Oct 31. pii: S0360-3016(19)33963.
    PubMed     Abstract available


  30. GIRALT J, Tao Y, Kortmann RD, Zasadny X, et al
    Randomized phase 2 trial of a novel clonidine mucoadhesive buccal tablet for the amelioration of oral mucositis in patients treated with concomitant chemo-radiotherapy for head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2019 Oct 25. pii: S0360-3016(19)33905.
    PubMed     Abstract available


  31. CHENG N, Liu Y, Zhao G, Xu Y, et al
    Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Advanced Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Oct 23. pii: S0360-3016(19)33909.
    PubMed     Abstract available


    September 2019
  32. VITZTHUM LK, Park H, Zakeri K, Bryant AK, et al
    Selection of Head and Neck Cancer Patients for Intensive Therapy.
    Int J Radiat Oncol Biol Phys. 2019 Sep 30. pii: S0360-3016(19)33835.
    PubMed     Abstract available


  33. SO N, McDowell LJ, Lu L, Xu W, et al
    The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.
    Int J Radiat Oncol Biol Phys. 2019 Sep 27. pii: S0360-3016(19)33828.
    PubMed     Abstract available


  34. YOUNG MR, Decker RH
    SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time.
    Int J Radiat Oncol Biol Phys. 2019;105:121-123.
    PubMed    


  35. MUELLER AC, Karam SD
    SBRT for Early Stage Larynx: A Go or No Go? It's All in the Delivery.
    Int J Radiat Oncol Biol Phys. 2019;105:119-120.
    PubMed    


  36. KANG BH, Yu T, Kim JH, Park JM, et al
    Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2019;105:104-109.
    PubMed     Abstract available


    August 2019
  37. WANG L, Liang S, Li C, Sun X, et al
    A novel nomogram and risk classification system predicting radiation pneumonitis in patients with esophageal cancer receiving radiotherapy.
    Int J Radiat Oncol Biol Phys. 2019 Aug 25. pii: S0360-3016(19)33659.
    PubMed     Abstract available


  38. GENSHEIMER MF, Le QT
    Radiographic Extranodal Extension in Human Papillomavirus-Associated Oropharyngeal Carcinoma: Can it Help Tailor Treatment?
    Int J Radiat Oncol Biol Phys. 2019;104:1028-1029.
    PubMed    


  39. BILLFALK-KELLY A, Yu E, Su J, O'Sullivan B, et al
    Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2019;104:1017-1027.
    PubMed     Abstract available


    July 2019
  40. HELD T, Windisch P, Akbaba S, Lang K, et al
    Carbon Ion Re-Irradiation for Recurrent Head-and-Neck Cancer: A Single-Institutional Experience.
    Int J Radiat Oncol Biol Phys. 2019 Jul 23. pii: S0360-3016(19)33504.
    PubMed     Abstract available


  41. SUN XS, Liu SL, Luo MJ, Li XY, et al
    The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012.
    Int J Radiat Oncol Biol Phys. 2019 Jul 15. pii: S0360-3016(19)33456.
    PubMed     Abstract available


  42. ANDERSON CM, Kimple RJ, Lin A, Karam SD, et al
    De-Escalation Strategies in HPV-Associated Oropharynx Cancer-Are we Putting the Cart Before the Horse?
    Int J Radiat Oncol Biol Phys. 2019;104:705-709.
    PubMed    


  43. WU J, Gensheimer MF, Zhang N, Han F, et al
    Integrating Tumor and Nodal Imaging Characteristics at Baseline and Mid-Treatment Computed Tomography Scans to Predict Distant Metastasis in Oropharyngeal Cancer Treated With Concurrent Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2019;104:942-952.
    PubMed     Abstract available


  44. LEE AW, Ng WT, Pan JJ, Chiang CL, et al
    International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Jul 2. pii: S0360-3016(19)33428.
    PubMed     Abstract available


  45. LESTER-COLL NH, Margalit DN
    Modeling the Potential Benefits of Proton Therapy for Patients With Oropharyngeal Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2019;104:563-566.
    PubMed    


  46. GOTTGENS EL, Bussink J, Leszczynska KB, Peters H, et al
    Inhibition of CD4/CDK6 enhances radiosensitivity of HPV negative head and neck squamous cell carcinomas.
    Int J Radiat Oncol Biol Phys. 2019 Jul 1. pii: S0360-3016(19)33419.
    PubMed     Abstract available


  47. CARTER RJ, Nickson CM, Thompson JM, Kacperek A, et al
    Characterisation of Deubiquitylating Enzymes in the Cellular Response to High-LET Ionizing Radiation and Complex DNA Damage.
    Int J Radiat Oncol Biol Phys. 2019;104:656-665.
    PubMed     Abstract available


  48. RWIGEMA JM, Langendijk JA, Paul van der Laan H, Lukens JN, et al
    A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2019;104:553-562.
    PubMed     Abstract available


    June 2019
  49. QIAN D, Wang Y, Zhao G, Cao F, et al
    Tumor Remission and tumor-infiltrating lymphocytes during chemoradiotherapy: predictive and prognostic markers in locally advanced esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Jun 19. pii: S0360-3016(19)30914.
    PubMed     Abstract available


  50. MEN K, Geng H, Zhong H, Fan Y, et al
    A deep learning model for predicting xerostomia due to radiotherapy for head-and-neck squamous cell carcinoma in the RTOG 0522 clinical trial.
    Int J Radiat Oncol Biol Phys. 2019 Jun 12. pii: S0360-3016(19)30834.
    PubMed     Abstract available


  51. CHUA MLK
    Circulating Tumor DNA to Personalize Treatment in Nasopharynx Cancer - Time to Look "Ahead"?
    Int J Radiat Oncol Biol Phys. 2019;104:362-364.
    PubMed    


    May 2019
  52. GREWAL AS, Jones J, Lin A
    Palliative radiation therapy for head and neck cancers.
    Int J Radiat Oncol Biol Phys. 2019 May 22. pii: S0360-3016(19)30746.
    PubMed     Abstract available


  53. MARGALIT DN, Haddad RI, Tishler RB, Chau NG, et al
    A phase I study of afatinib in combination with postoperative radiation therapy with and without weekly docetaxel in intermediate- and high-risk patients with resected squamous cell carcinoma of the head and neck.
    Int J Radiat Oncol Biol Phys. 2019 May 10. pii: S0360-3016(19)30698.
    PubMed     Abstract available


  54. HUANG XD, Li YC, Chen FP, Zheng WH, et al
    Evolution and Dosimetric Analysis of MRI-detected Brainstem Injury Following Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 May 7. pii: S0360-3016(19)30694.
    PubMed     Abstract available


  55. HALLEMEIER CL, Olsen JR, Murphy JD, Tait D, et al
    Gastrointestinal Cancers: Management of Rectal, Hepatocellular, Pancreatic, and Esophageal Cancers.
    Int J Radiat Oncol Biol Phys. 2019;104:1-9.
    PubMed    


    April 2019
  56. ZHAO C, Miao JJ, Hua YJ, Wang L, et al
    Excellent Locoregional Control and Mild Late Toxicity after Reducing Target Volumes and Radiation Doses in Locoregionally Advanced Nasopharyngeal Carcinoma Patients Treated with Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: Ten
    Int J Radiat Oncol Biol Phys. 2019 Apr 4. pii: S0360-3016(19)30570.
    PubMed     Abstract available


  57. LIM TY, Gillespie E, Murphy J, Moore KL, et al
    Clinically Oriented Contour Evaluation Using Dosimetric Indices Generated From Automated Knowledge-Based Planning.
    Int J Radiat Oncol Biol Phys. 2019;103:1251-1260.
    PubMed     Abstract available


  58. VAWDA N, Banerjee RN, Debenham BJ
    Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery.
    Int J Radiat Oncol Biol Phys. 2019;103:1125-1131.
    PubMed     Abstract available


    March 2019
  59. MCCLELLAND S 3RD, Watson GA
    The Headache of Hearing Loss.
    Int J Radiat Oncol Biol Phys. 2019;103:796-797.
    PubMed    


  60. PIKE LRG, McKenna MJ, Shih HA
    With Regard to the Brainstem, Size Matters Most.
    Int J Radiat Oncol Biol Phys. 2019;103:799-800.
    PubMed    


  61. LO SS, Chang EL
    Preserve the Facial Nerve.
    Int J Radiat Oncol Biol Phys. 2019;103:798-799.
    PubMed    


  62. BALAGAMWALA EH, Suh JH
    Resection First.
    Int J Radiat Oncol Biol Phys. 2019;103:798.
    PubMed    


  63. CZERWINSKI MD, van Leeuwen RGH, Kaanders JHAM, Zwijnenburg EM, et al
    Image Guided Brachytherapy for Cancer of the Nasal Vestibule: Local Control and Cosmesis.
    Int J Radiat Oncol Biol Phys. 2019;103:913-921.
    PubMed     Abstract available


  64. SHER DJ, Timmerman RD, Nedzi L, Ding C, et al
    Phase I fractional dose escalation study of equipotent stereotactic radiotherapy regimens for early-stage glottic larynx cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 14. pii: S0360-3016(19)30323.
    PubMed     Abstract available


  65. SANFORD NN, Lau J, Lam MB, Juliano AF, et al
    Individualization of Clinical Target Volume Delineation Based on Stepwise Spread of Nasopharyngeal Carcinoma: Outcome of More Than a Decade of Clinical Experience.
    Int J Radiat Oncol Biol Phys. 2019;103:654-668.
    PubMed     Abstract available


  66. PEARLSTEIN KA, Wang K, Amdur RJ, Shen CJ, et al
    Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2019;103:646-653.
    PubMed     Abstract available


    February 2019
  67. BOURGIER C, Auperin A, Rivera S, Boisselier P, et al
    Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients with Head and Neck Cancer: Results of the Biology-Driven Phase Ii Clinical Trial Pravacur.
    Int J Radiat Oncol Biol Phys. 2019 Feb 15. pii: S0360-3016(19)30250.
    PubMed     Abstract available


  68. SHURYAK I, Hall EJ, Brenner DJ
    Optimized Hypofractionation can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Feb 15. pii: S0360-3016(19)30251.
    PubMed     Abstract available


    January 2019
  69. HUANG CL, Sun ZQ, Guo R, Liu X, et al
    Plasma Epstein-Barr Virus DNA Load after Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Jan 22. pii: S0360-3016(19)30048.
    PubMed     Abstract available


  70. WU L, Chung YL
    Tumor-infiltrating T-cell Receptor-beta Repertoires are Linked to the Risk of Late Chemoradiation-induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Jan 14. pii: S0360-3016(19)30037.
    PubMed     Abstract available


    December 2018
  71. BAKST RL, Glastonbury CM, Parvathaneni U, Katabi N, et al
    Perineural Invasion and Perineural Tumor Spread in Head and Neck Cancer: A Critical Review.
    Int J Radiat Oncol Biol Phys. 2018 Dec 15. pii: S0360-3016(18)34175.
    PubMed     Abstract available


    November 2018
  72. ADJEIWAAH M, Bylund M, Lundman JA, Soderstrom K, et al
    Dosimetric Impact of MRI distortions - A study on Head and Neck Cancers.
    Int J Radiat Oncol Biol Phys. 2018 Nov 26. pii: S0360-3016(18)34023.
    PubMed     Abstract available


  73. BRODIN NP, Kabarriti R, Pankuch M, Schechter CB, et al
    A Quantitative Clinical Decision-support Strategy Identifying Which Oropharyngeal Head and Neck Cancer Patients may Benefit the Most from Proton Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018 Nov 26. pii: S0360-3016(18)34025.
    PubMed     Abstract available


  74. JI Z, Jiang Y, Tian S, Guo F, et al
    The Effectiveness and Prognostic Factors of CT-guided Radioactive Iodine-125 Seed Implantation for the Treatment of Recurrent Head and Neck Cancer after External Beam Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Nov 1. pii: S0360-3016(18)33923.
    PubMed     Abstract available


    October 2018
  75. PINDER-ARABPOUR A, Jones B, Castillo R, Castillo E, et al
    Characterizing Spatial Lung Function For Esophageal Cancer Patients Undergoing Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Oct 26. pii: S0360-3016(18)33913.
    PubMed     Abstract available


  76. BRITTON B, Baker AL, Wolfenden L, Wratten C, et al
    Eating As Treatment (EAT): a stepped-wedge, randomised controlled trial of a health behaviour change intervention provided by dietitians to improve nutrition in patients with head and neck cancer undergoing radiotherapy (TROG 12.03).
    Int J Radiat Oncol Biol Phys. 2018 Oct 5. pii: S0360-3016(18)33807.
    PubMed     Abstract available


  77. MCDOWELL LJ, Rock K, Xu W, Chan B, et al
    Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;102:340-352.
    PubMed     Abstract available


  78. OLSEN JR, Murphy JD, Huguet F, Hallemeier CL, et al
    Gastrointestinal Cancers-Carving Out the Optimal Local Therapies in the Gastrointestinal Tract.
    Int J Radiat Oncol Biol Phys. 2018;102:233-242.
    PubMed    


  79. KOTO M, Demizu Y, Saitoh JI, Suefuji H, et al
    Definitive Carbon-Ion Radiation Therapy for Locally Advanced Sinonasal Malignant Tumors: Subgroup Analysis of a Multicenter Study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
    Int J Radiat Oncol Biol Phys. 2018;102:353-361.
    PubMed     Abstract available


    September 2018
  80. JIN P, Machiels M, Crama KF, Visser J, et al
    Dosimetric benefits of mid-position compared with internal target volume strategy for esophageal cancer radiation therapy.
    Int J Radiat Oncol Biol Phys. 2018 Sep 22. pii: S0360-3016(18)33804.
    PubMed     Abstract available


  81. LU S, Wei J, Sun F, Xiao W, et al
    Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors after Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Sep 20. pii: S0360-3016(18)33762.
    PubMed     Abstract available


    July 2018
  82. TANDBERG DJ, Cui Y, Rushing CN, Hong JC, et al
    Intra-treatment response assessment with 18F-FDG PET: Correlation of semi-quantitative PET features with pathologic response of esophageal cancer to neoadjuvant chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Jul 25. pii: S0360-3016(18)31640.
    PubMed     Abstract available


  83. LIU Q, Liang J, Zhou D, Krauss DJ, et al
    Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Int J Radiat Oncol Biol Phys. 2018;101:985-997.
    PubMed     Abstract available


  84. JABBOUR SK, Apisarnthanarax S, Hallemeier CL, Huguet F, et al
    GI Cancers-Modulating the Modern Management of Gastrointestinal Malignancies: A Look at Liver Metastases, Rectal Cancer, Esophagogastric Cancer, and Anal Cancer.
    Int J Radiat Oncol Biol Phys. 2018;101:749-758.
    PubMed    


  85. BLITZER GC, Rosenberg SA, Anderson BM, McCulloch TM, et al
    Results From a Free Oral Cancer Screening Clinic at a Major Academic Health Center: 10 Years of Free Oral Cancer Screening at an Academic Medical Center.
    Int J Radiat Oncol Biol Phys. 2018 Jul 3. pii: S0360-3016(18)30800.
    PubMed    


  86. NANDA SS, Gandhi AK, Rastogi M, Khurana R, et al
    Evaluation of XRCC1 Gene Polymorphism as a Biomarker in Head and Neck Cancer Patients Undergoing Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;101:593-601.
    PubMed     Abstract available


    June 2018
  87. HAN P, Wang X, Liang F, Liu Y, et al
    =Osteoradionecrosis of the Skull Base in Nasopharyngeal Carcinoma: Incidence and Risk Factors.
    Int J Radiat Oncol Biol Phys. 2018 Jun 27. pii: S0360-3016(18)31018.
    PubMed     Abstract available


  88. GRECO E, Simic T, Ringash J, Tomlinson G, et al
    Dysphagia Treatment for Patients With Head and Neck Cancer Undergoing Radiation Therapy: A Meta-analysis Review.
    Int J Radiat Oncol Biol Phys. 2018;101:421-444.
    PubMed     Abstract available


  89. CARDENAS CE, McCarroll RE, Court LE, Elgohari BA, et al
    Deep Learning Algorithm for Auto-Delineation of High-Risk Oropharyngeal Clinical Target Volumes With Built-In Dice Similarity Coefficient Parameter Optimization Function.
    Int J Radiat Oncol Biol Phys. 2018;101:468-478.
    PubMed     Abstract available


    May 2018
  90. NG WT, Tung SY, Lee V, Ngan RKC, et al
    Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic Ratio.
    Int J Radiat Oncol Biol Phys. 2018 May 2. pii: S0360-3016(18)30747.
    PubMed     Abstract available


  91. XU Y, Rong X, Hu W, Huang X, et al
    Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2018 May 2. pii: S0360-3016(18)30746.
    PubMed     Abstract available


  92. WU H, Chen X, Yang X, Tao Y, et al
    Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT.
    Int J Radiat Oncol Biol Phys. 2018 May 1. pii: S0360-3016(18)30737.
    PubMed     Abstract available


    April 2018
  93. BOSSI P, Miceli R, Granata R, Naimo S, et al
    Failure of Further Validation for Survival Nomograms in Oropharyngeal Cancer: Issues and Challenges.
    Int J Radiat Oncol Biol Phys. 2018;100:1217-1221.
    PubMed     Abstract available


    March 2018
  94. ZHOU GQ, Wu CF, Zhang J, Mao YP, et al
    Cost-Effectiveness Analysis of Routine Magnetic Resonance Imaging in the Follow-Up of Patients With Nasopharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018 Mar 30. pii: S0360-3016(18)30541.
    PubMed     Abstract available


  95. BEADLE BM, Anderson CM
    CTV Guidance for Head and Neck Cancers.
    Int J Radiat Oncol Biol Phys. 2018;100:903-905.
    PubMed    


  96. LIN L, Lu Y, Wang XJ, Chen H, et al
    Delineation of Neck Clinical Target Volume Specific to Nasopharyngeal Carcinoma Based on Lymph Node Distribution and the International Consensus Guidelines.
    Int J Radiat Oncol Biol Phys. 2018;100:891-902.
    PubMed     Abstract available


  97. YOM SS, Harari PM
    When Disaster Strikes: Mitigating the Adverse Impact on Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2018;100:838-840.
    PubMed    


  98. FANG P, Musall BC, Son JB, Moreno AC, et al
    Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30328.
    PubMed     Abstract available


  99. NG WT, Ngan RKC, Kwong DLW, Tung SY, et al
    Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:630-638.
    PubMed     Abstract available


  100. LI Y, Huang X, Jiang J, Hu W, et al
    Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Int J Radiat Oncol Biol Phys. 2018;100:621-629.
    PubMed     Abstract available


  101. MARGALIT DN, Wong SJ
    Reirradiation for Head and Neck Cancer: The Who and the How.
    Int J Radiat Oncol Biol Phys. 2018;100:618-620.
    PubMed    


  102. CAUDELL JJ, Ward MC, Riaz N, Zakem SJ, et al
    Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis.
    Int J Radiat Oncol Biol Phys. 2018;100:606-617.
    PubMed     Abstract available


  103. OVERGAARD J
    In Regards to Stokes et al and Bledsoe et al.
    Int J Radiat Oncol Biol Phys. 2018;100:804-805.
    PubMed    


  104. LAIRD J, Ma J, Chau K, Chelius M, et al
    Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.
    Int J Radiat Oncol Biol Phys. 2018;100:670-678.
    PubMed     Abstract available


  105. HEGDE JV, Shaverdian N, Felix C, Wang PC, et al
    Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2018;100:647-651.
    PubMed     Abstract available


    February 2018
  106. POTEZ M, Bouchet A, Wagner J, Donzelli M, et al
    Effects of Synchrotron X-Ray Micro-beam Irradiation on Normal Mouse Ear Pinnae.
    Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30254.
    PubMed     Abstract available


  107. ZHENG B, Zhu X, Liu M, Yang Z, et al
    Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;100:418-426.
    PubMed     Abstract available


  108. BRODIN NP, Kabarriti R, Garg MK, Guha C, et al
    Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.
    Int J Radiat Oncol Biol Phys. 2018;100:391-407.
    PubMed     Abstract available


  109. ANDERSON CM, Sonis ST, Lee CM, Adkins D, et al
    Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:427-435.
    PubMed     Abstract available


    January 2018
  110. VARGO JA, Moiseenko V, Grimm J, Caudell J, et al
    Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group.
    Int J Radiat Oncol Biol Phys. 2018 Jan 31. pii: S0360-3016(18)30107.
    PubMed     Abstract available


  111. SHEMESH R, Alon EE, Gluck I, Yakirevitch A, et al
    Endoscopic Surgery for Delayed Sinonasal Complications of Radiation Therapy for Nasopharyngeal Carcinoma: A Subjective Outcome.
    Int J Radiat Oncol Biol Phys. 2018 Jan 9. pii: S0360-3016(18)30052.
    PubMed     Abstract available


    December 2017
  112. MAGUIRE PD, Neal CR, Hardy SM, Schreiber AM, et al
    Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
    Int J Radiat Oncol Biol Phys. 2017 Dec 28. pii: S0360-3016(17)34503.
    PubMed     Abstract available


  113. TENG F, Aryal M, Lee J, Lee C, et al
    Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers.
    Int J Radiat Oncol Biol Phys. 2017 Dec 21. pii: S0360-3016(17)34492.
    PubMed     Abstract available


  114. QUON H, Hui X, Cheng Z, Robertson S, et al
    Quantitative Evaluation of Head and Neck Cancer Treatment-Related Dysphagia in the Development of a Personalized Treatment Deintensification Paradigm.
    Int J Radiat Oncol Biol Phys. 2017;99:1271-1278.
    PubMed     Abstract available


  115. MAN LC, Axelrod R
    Not All Head and Neck Squamous Cell Carcinomas Are Created Equal: Some Are More Aggressive.
    Int J Radiat Oncol Biol Phys. 2017;99:1063.
    PubMed    


  116. WITEK ME
    Are All Head and Neck Squamous Cell Carcinomas Created Equal?
    Int J Radiat Oncol Biol Phys. 2017;99:1059-1060.
    PubMed    


    November 2017
  117. ROUTMAN DM, Funk RK, Tangsriwong K, Lin A, et al
    Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional Review.
    Int J Radiat Oncol Biol Phys. 2017;99:938-946.
    PubMed     Abstract available


  118. WARREN S, Hurt CN, Crosby T, Partridge M, et al
    Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2017;99:729-737.
    PubMed     Abstract available


  119. XI M, Xu C, Liao Z, Chang JY, et al
    Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;99:667-676.
    PubMed     Abstract available


  120. TAO Y, Auperin A, Sire C, Martin M, et al
    Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;99:590-595.
    PubMed     Abstract available


    October 2017
  121. GURNEY-CHAMPION OJ, McQuaid D, Dunlop A, Wong KH, et al
    MRI-based Assessment of 3D Intrafractional Motion of Head and Neck Cancer for Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017 Oct 16. pii: S0360-3016(17)34020.
    PubMed     Abstract available


    September 2017
  122. YOSHIDA EJ, Luu M, David JM, Kim S, et al
    Facility Volume and Survival in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2017 Sep 28. pii: S0360-3016(17)33938.
    PubMed     Abstract available


  123. LO A, Ayre G, Ma R, Hsu F, et al
    Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
    Int J Radiat Oncol Biol Phys. 2017 Sep 18. pii: S0360-3016(17)33891.
    PubMed     Abstract available


    April 2017
  124. VARGO JA, Ward MC, Caudell JJ, Riaz N, et al
    A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Apr 24. pii: S0360-3016(17)30821.
    PubMed     Abstract available


  125. YOM SS
    A Larynx Best Preserved, but by Radiation or Formalin?
    Int J Radiat Oncol Biol Phys. 2017;97:889-890.
    PubMed    


    January 2017
  126. YOM SS
    The Tonsillar Fossa Battleground.
    Int J Radiat Oncol Biol Phys. 2017;97:1-2.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: